Keyphrases
PET Imaging
100%
Everolimus
100%
Human Tumor Xenograft
100%
Tumor Growth
100%
18F-fluorodeoxyglucose (18F-FDG)
100%
Neuroendocrine Tumor
100%
Tumor Research
100%
18F-FLT
75%
Treatment Monitoring
25%
MTOR Inhibitor
12%
Early Identification
12%
Xenograft Tumor
12%
Human Xenografts
12%
Tumor Volume
12%
Non-responders
12%
Treatment Group
12%
Tumor Patients
12%
MTT Assay
12%
Placebo
12%
Cell Proliferation
12%
Early Response
12%
Lung Carcinoid
12%
In Vivo Applications
12%
Treatment Effect
12%
PET Scan
12%
Proliferation in Vitro
12%
Tailored Therapy
12%
Medicine and Dentistry
Neuroendocrine Tumor
100%
Tumor Progression
100%
Fluorodeoxyglucose F 18
100%
Tumor Xenograft
100%
positron emission tomographic scan
100%
Everolimus
100%
Fluorine-18
100%
In Vitro
50%
Treatment Response
25%
Neoplasm
12%
Mammalian Target of Rapamycin Inhibitor
12%
Positron Emission Tomography-Computed Tomography
12%
Polyethylene Terephthalate
12%
Lung
12%
Treatment Effect
12%
Xenograft
12%
Radioactive Tracer
12%
Carcinoid
12%
Cell Proliferation
12%
Placebo
12%
Treatment Group
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorine 18
100%
Everolimus
100%
Tumor Growth
100%
Neuroendocrine Tumor
100%
Neoplasm
100%
Fluorodeoxyglucose F 18
100%
Polyethylene Terephthalate
100%
Carcinoid
25%
Tracer
12%
Placebo
12%
Treatment Group
12%
Mammalian Target of Rapamycin Inhibitor
12%
Neuroscience
Everolimus
100%
Fluorine-18
100%
positron emission tomographic scan
100%
In Vivo
30%
In Vitro
30%
Carcinoid
15%
Cell Proliferation
7%
Positron Emission Tomography
7%
Positron Emission Tomography-Computed Tomography
7%
Placebo
7%
MTT Assay
7%
Cell Line
7%